Brain

Praxis Precision Medicines Appoints Global Epilepsy Leader Dr. Orrin Devinsky as Head of Clinical Strategy

BOSTON, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system…

4 weeks ago

The Mark Foundation for Cancer Research Announces 2026 Emerging Leader Awards, Committing $3.75 Million to Next-Generation Oncology Breakthroughs

Since 2018, more than $40 million has been granted to support outstanding cancer research projects by early-career scientistsNEW YORK, Jan.…

4 weeks ago

GrayMatters Health Announces New Research Expanding Scientific Validity and Clinical Impact of fMRI-Informed Biomarkers

Findings bridge groundbreaking science with real-world clinical practiceNEW YORK, Jan. 13, 2026 /PRNewswire/ -- GrayMatters Health (GMH), the pioneers of digital…

4 weeks ago

Ability Center brings Cognoa’s Canvas Dx to Saudi Arabia, giving families faster, more precise autism evaluations in early childhood

NEWPORT BEACH, Calif., Jan. 13, 2026 /PRNewswire/ -- Cognoa and The Ability Center today announced the exclusive availability in Saudi…

4 weeks ago

Stroke Experts Challenge “90-Day Recovery” Myth: New Research Shows Patients Need Long-Term Care

Study published by Centre for Neuro Skills researchers in Brain Injury journal argues current insurance policies leave stroke survivors with…

4 weeks ago

Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects 

– Annamycin consistently demonstrates no evidence of cardiotoxicity across five clinical trials – This next-generation anthracycline demonstrates safety and promising…

4 weeks ago

CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital

SINGAPORE, Jan. 13, 2026 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage…

4 weeks ago

XTL Biopharmaceuticals Acquires 85% of Beyond Air’s Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

Unmatched scientific firepower: Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in…

4 weeks ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the…

4 weeks ago